0001225208-11-025361.txt : 20111123 0001225208-11-025361.hdr.sgml : 20111123 20111123164953 ACCESSION NUMBER: 0001225208-11-025361 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20111116 FILED AS OF DATE: 20111123 DATE AS OF CHANGE: 20111123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guilmette David D CENTRAL INDEX KEY: 0001535396 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08323 FILM NUMBER: 111225735 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CIGNA CORP CENTRAL INDEX KEY: 0000701221 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 061059331 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20111019 FORMER COMPANY: FORMER CONFORMED NAME: CIGNA CORP DATE OF NAME CHANGE: 19920703 3 1 doc3.xml X0204 3 2011-11-16 0 0000701221 CIGNA CORP CI 0001535396 Guilmette David D 900 COTTAGE GROVE ROAD BLOOMFIELD CT 06002 1 Pres. Nat'l, Pharm. & Product Common Stock, $.25 Par Value 17319.0000 D Employee Stock Option (Right to Buy) 34.6450 2011-03-03 2020-03-03 Common Stock, $.25 Par Value 26282.0000 D Employee Stock Option (Right to Buy) 42.1900 2012-03-01 2021-03-01 Common Stock, $.25 Par Value 10429.0000 D This option vests in three equal annual installments. The first installment became exercisable on March 3, 2011, and the next two installments become exercisable on March 3, 2012 and March 3, 2013. This option vests in three equal annual installments beginning March 1, 2012. Exhibit 24 - Power of Attorney poaguilmette.txt By: Lindsay K. Blackwood, attorney-in-fact 2011-11-23 EX-24 2 poaguilmette.txt POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned, an officer of Cigna Corporation, a Delaware corporation ("Cigna"), hereby makes, designates, constitutes and appoints NICOLE S. JONES, LINDSAY K. BLACKWOOD, and AUDREY B. TARANTO, each acting individually, as the undersigned's true and lawful attorneys-in-fact and agents, with full power and authority to act in the undersigned's capacity as an officer of Cigna for and in the name, place and stead of the undersigned in connection with the filing with the Securities and Exchange Commission pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934, both as amended, of the execution and delivery of Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, Forms 144 in accordance with Rule 144 promulgated under the Securities Act of 1933 and any and all other documents related thereto (including, but not limited to, Seller's Representation Letters) and to take further action as they, or any of them, deem appropriate in connection with the foregoing. Such attorneys-in-fact and agents, or any of them, are also hereby granted full power and authority, on behalf of and in the name, place and stead of the undersigned, to execute and deliver all such amendments, qualifications and notifications; to execute and deliver any and all such other documents; and to take further action as they, or any of them, deem appropriate in connection with the foregoing. The powers and authorities granted herein to such attorneys-in-fact and agents, and each of them, also include the full right, power and authority to effect necessary or appropriate substitutions or revocations. The undersigned hereby ratifies, confirms, and adopts, as his own act and deed, all action lawfully taken by such attorneys-in-fact and agents, or any of them, or by their respective substitutes, pursuant to the powers and authorities herein granted. This Power of Attorney shall remain in full force and effect until the undersigned no longer has responsibilities relating to Section 16 of the Securities Exchange Act of 1934 or Rule 144 promulgated under the Securities Act of 1933 with respect to the undersigned's beneficial ownership of securities of Cigna, unless earlier revoked by the undersigned in a signed writing to each such attorney in fact. IN WITNESS WHEREOF, the undersigned has executed this document as of the 21st day of November, 2011. /s/ David D. Guilmette David Guilmette